Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Avaliação do grau de incapacidade neurofuncional dos pacientes com diagnóstico de Hanseníase/ Assessment of the degree of neurofunctional disability in patients diagnosed with leprosy

Oliveira PDS, Silva AMFD, Neto LRDS, et al. South Florida Publishing LLC. Brazilian Journal of Health Review. 2021; 4 (4) : 15870-15887.
Download PDF
Publication

The First Case Report of Pulmonary Hypertension in Leprosy

Siregar M, Wahidji V. Iranian Heart Journal. 2024;
Download PDF
Publication

Immune-Mediated Glomerulonephritis as Type 2 Lepra Reaction Posttreatment of Lepromatous Leprosy: A Case Report.

Kantak D, Dsouza M. Indian journal of nephrology. 2024; 34 (5) : 520-521.
Download PDF
Publication

Hubungan Dukungan Keluarga dengan Harga Diri Pada Pasien Kusta di Klinik Kulit dan Kelamin RSUD dr. Saiful Anwar Malang

Suhermin Y. Jurnal Keperawatan Muhammadiyah. 2024;
Download PDF
Publication

Diagnostic Enigma in a Rare Case of Primary Neuritic Leprosy

Ahmed S, Rahman A, Ahmed T, et al. Bangladesh Academy of Sciences. Bangladesh Journal of Medicine. 2024; 35 (3) : 214-217.
Download PDF
Publication

Profile of Leprosy Patients at the Dermatology and Venereology Polyclinic of Dr. M. Djamil Padang Hospital in 2018-2021

Habib El Binampiy Busnia , Gustia Rina , Deddy Herman . Asosiasi Penelitian dan Pengajar Ilmu Hukum Indonesia. International Journal of Health and Medicine. 2024; 1 (4) : 120-133.
Download PDF
Publication

Hanseníase: muito além da pele – o impacto sistêmico e psicológico no paciente com a doença

Zanuto T, Amália Santos Schiochet Pontes , Evelyn Thamara de Almeida Fortunato , et al. Brazilian Journal of Implantology and Health Sciences. Brazilian Journal of Implantology and Health Sciences. 2024; 6 (10) : 1092-1104.
Download PDF
Publication

Clinically Suspicious Cases of Hansen's Disease at a Tertiary Care Hospital in South India: A Clinicopathological Study

Shabnam A, Dennis Joseph L, Priyathersini N, et al. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF
Publication

Lepra: enfermedad reemergente

Hincapie DAF, Rozo EFM, Agudelo LG, et al. Dermatology Mexican Megazine. 2024;
Download PDF
Publication

Epidemiología y clínica de los pacientes con lepra en un centro de referencia de Paraguay

Re Domínguez ML, Olmedo OMA. Instituto de Investigaciones en Ciencias de la Salud. Revista del Nacional (Itauguá). 2024; 16 (3) : 1-13.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 67
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD